Collaborating with Apollo Therapeutics: bridging the gap from Academia to Pharma - first steps on the translation from bench to bedside

OxTalks is Changing

During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).

If you have any questions, please contact halo@digital.ox.ac.uk

Collaborating with Apollo Therapeutics: bridging the gap from Academia to Pharma - first steps on the translation from bench to bedside

Apollo Therapeutics is a portfolio biopharmaceutical company based in the UK and USA. They translate breakthroughs in biology and basic medical research into innovative new medicines. With over 20 active therapeutic programs, six of which are in development, they are building a large, diversified portfolio of novel therapeutics with uncorrelated risk. Apollo Therapeutics and the University of Oxford have entered into drug discovery and development collaboration

The seminar will be followed by lunch and and networking.

Date: 2 October 2025, 12:00
Venue:
IMS-Tetsuya Nakamura Building
Roosevelt Dr, Headington OX3 7TY
See location on maps.ox

Details: Ground Floor Seminar Room
Speaker: Dr (Kay Penicud)
Organising department: Divisional Office (MSD)
Organisers: Medical Sciences Division Business Partnerships Office (University of Oxford), Elizabeth Covey-Crump (MSD Business Partnerships Office), Sheena Lee (MSD Business Partnerships Office)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Elizabeth Covey-Crump (MSD Business Partnerships Office)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://forms.office.com/e/T44Q8kEs0r
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
- Innovation & Translation related talks
Editor: Sheena Lee